BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37722316)

  • 1. Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack.
    Yoshimoto T; Ishiyama H; Hattori Y; Nishimura K; Okada Y; Watanabe H; Ohyagi Y; Akaiwa Y; Miyamoto T; Kawamoto M; Ichijo M; Inoue H; Matsukawa N; Mizuno T; Matsuyama H; Tomimoto H; Kawakami D; Toyoda K; Koga M; Ihara M
    Atherosclerosis; 2023 Oct; 382():117281. PubMed ID: 37722316
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Eto F; Yoshimoto T; Okazaki S; Nishimura K; Ogura S; Yamaguchi E; Fukuma K; Saito S; Washida K; Koga M; Toyoda K; Morimoto T; Maruyama H; Koizumi A; Ihara M
    Front Aging Neurosci; 2021; 13():681743. PubMed ID: 34335228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden.
    Ohara M; Yoshimoto T; Okazaki S; Gon Y; Todo K; Sasaki T; Takasugi J; Ohara N; Ihara M; Mochizuki H
    J Atheroscler Thromb; 2022 Nov; 29(11):1655-1662. PubMed ID: 34955493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and intracranial arterial lesions of non-young adult ischemic stroke patients with RNF213 p.R4810K variant.
    Ogura S; Ohara T; Tanaka E; Ashida S; Maezono-Kandori K; Hanya M; Mizuta I; Mizuno T
    J Neurol Sci; 2023 Sep; 452():120775. PubMed ID: 37657303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of RNF213 p.R4810K Variant in Early-Onset Stroke With Intracranial Arterial Stenosis.
    Kamimura T; Okazaki S; Morimoto T; Kobayashi H; Harada K; Tomita T; Higashiyama A; Yoshimoto T; Takahashi JC; Nakagawara J; Koga M; Toyoda K; Maruyama H; Koizumi A; Ihara M
    Stroke; 2019 Jun; 50(6):1561-1563. PubMed ID: 31060437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the
    Okazaki S; Yoshimoto T; Ohara M; Takagaki M; Nakamura H; Watanabe K; Gon Y; Todo K; Sasaki T; Araki H; Yamada T; Manabe S; Kishima H; Ihara M; Mochizuki H
    Neurol Genet; 2022 Oct; 8(5):e200029. PubMed ID: 36324634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed phenotype of
    Zhou H; Jing J; Pu Y; Li W; Meng X; Wang A; Zuo Y; Xu Z; Xu Q; Suo Y; Li H; Wang Y
    Stroke Vasc Neurol; 2023 Dec; 8(6):503-510. PubMed ID: 37137523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
    Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
    Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
    Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
    Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With 
    Noda K; Hattori Y; Hori M; Nakaoku Y; Tanaka A; Yoshimoto T; Nishimura K; Yokota T; Harada-Shiba M; Ihara M
    JACC Asia; 2023 Aug; 3(4):625-633. PubMed ID: 37614551
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
    J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
    Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
    Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
    PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.